Comparing Teaching Styles and Personality Types of EFL Instructors in the Public and Private Sectors

This is an exploratory non-experimental research study whose main objective is to compare the teaching styles of a group of thirty teachers of English working in either public or private secondary education in Chile. In order to collect the required data, two instruments were administered to the participants: a teaching style inventory and a personality type index proposed by Grasha. Results indicate that public sector participants show a facilitator teaching style and an extrovert personality type, whereas private sector participants reveal a more authoritative teaching style and an introverted type of personality

Comparing teaching styles and personality types of efl instructors in the public and private sectors

This is an exploratory non-experimental research study whose main objective is to compare the teaching styles of a group of thirty teachers of English working in either public or private secondary education in Chile. In order to collect the required data, two instruments were administered to the participants: a teaching style inventory and a personality type index proposed by Grasha. Results indicate that public sector participants show a facilitator teaching style and an extrovert personality type, whereas private sector participants reveal a more authoritative teaching style and an introverted type of personality.Este estudio exploratorio de naturaleza no-experimental tiene como objetivo principal comparar los estilos de enseñanza de un grupo de treinta profesores de inglés que trabajan en el nivel de enseñanza secundario del sistema educativo estatal o privado, en Chile. Para la recolección de datos se utilizaron el inventario de estilos de enseñanza y el índice de tipo de personalidad de Grasha. Los resultados indican que los participantes del nivel de enseñanza estatal presentan un estilo de enseñanza de naturaleza facilitadora y un tipo de personalidad extrovertido, mientras que los participantes del nivel de enseñanza privado revelan un estilo de enseñanza más autoritario y una personalidad más introvertida

Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes

BACKGROUND: The cardiovascular effects of adding once-weekly treatment with exenatide to usual care in patients with type 2 diabetes are unknown. METHODS: We randomly assigned patients with type 2 diabetes, with or without previous cardiovascular disease, to receive subcutaneous injections of extended-release exenatide at a dose of 2 mg or matching placebo once weekly. The primary composite outcome was the first occurrence of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke. The coprimary hypotheses were that exenatide, administered once weekly, would be noninferior to placebo with respect to safety and superior to placebo with respect to efficacy. RESULTS: In all, 14,752 patients (of whom 10,782 [73.1%] had previous cardiovascular disease) were followed for a median of 3.2 years (interquartile range, 2.2 to 4.4). A primary composite outcome event occurred in 839 of 7356 patients (11.4%; 3.7 events per 100 person-years) in the exenatide group and in 905 of 7396 patients (12.2%; 4.0 events per 100 person-years) in the placebo group (hazard ratio, 0.91; 95% confidence interval [CI], 0.83 to 1.00), with the intention-to-treat analysis indicating that exenatide, administered once weekly, was noninferior to placebo with respect to safety (P<0.001 for noninferiority) but was not superior to placebo with respect to efficacy (P=0.06 for superiority). The rates of death from cardiovascular causes, fatal or nonfatal myocardial infarction, fatal or nonfatal stroke, hospitalization for heart failure, and hospitalization for acute coronary syndrome, and the incidence of acute pancreatitis, pancreatic cancer, medullary thyroid carcinoma, and serious adverse events did not differ significantly between the two groups. CONCLUSIONS: Among patients with type 2 diabetes with or without previous cardiovascular disease, the incidence of major adverse cardiovascular events did not differ significantly between patients who received exenatide and those who received placebo